Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
It includes multiple trials studying retatrutide in different populations: TRIUMPH-1 (obesity/overweight without type 2 diabetes, NCT05929066), TRIUMPH-3 (severe obesity + cardiovascular disease, NCT05882045), TRIUMPH-9 (dose-escalation in obesity, NCT07357415), and TRIUMPH-Outcomes (cardiovascular and kidney outcomes in adults with obesity, NCT06383390)
Some patients may also experience mild temporary side effects such as: Injection site soreness Redness or swelling Headache Nausea Mild muscle cramping These effects are generally mild and resolve quickly
This low-dose formulation is ideal for patients who require lower systemic exposure, offering effective results with a reduced risk of side effects
Light to moderate exercise enhances fat loss and improves muscle tone
It helps with weight loss by slowing down the time it takes for the stomach to empty
Efficacy and safety of glucagon-like peptide-1 receptor agonists for weight loss among adults without diabetes: a systematic review of randomized controlled trials
US$ 21.81
US$ 29.29
US$ 28.50
US$ 20.48
US$ 22.19
